| NASDAQ (usa) |
|
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
| DAX (german) |
|
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Guizhou Bailing Group Pharmaceutical Co. Ltd (SHE: 002424)
002424 Technical Analysis
4
| As on 24th Dec 2025 002424 STOCK Price closed @ 5.08 and we RECOMMEND Buy for LONG-TERM with Stoploss of 4.73 & Strong Buy for SHORT-TERM with Stoploss of 3.88 we also expect STOCK to react on Following IMPORTANT LEVELS. |
002424STOCK Price
| Open | 5.08 | Change | Price | % |
| High | 5.08 | 1 Day | -0.27 | -5.05 |
| Low | 5.08 | 1 Week | -0.27 | -5.05 |
| Close | 5.08 | 1 Month | -0.93 | -15.47 |
| Volume | 275400 | 1 Year | 1.05 | 26.05 |
| 52 Week High 6.65 | 52 Week Low 3.54 | ||||
SHE China Most Active Stocks
| 000981 | 3.61 | 0.56% |
| 002131 | 5.24 | 2.95% |
| 000725 | 4.06 | 0.50% |
| 000547 | 24.93 | 9.34% |
| 000592 | 13.49 | 3.06% |
| 002426 | 3.51 | 7.01% |
| 002596 | 6.22 | -4.01% |
| 000796 | 7.84 | 9.96% |
| 002600 | 16.00 | 3.09% |
| 000564 | 2.59 | 0.00% |
SHE China Top Gainers Stocks
SHE China Top Losers Stocks
| 002424 Daily Charts |
002424 Intraday Charts |
Whats New @ Bazaartrend |
002424 Free Analysis |
|
|
002424 Important Levels Intraday
| RESISTANCE | 5.08 |
| RESISTANCE | 5.08 |
| RESISTANCE | 5.08 |
| RESISTANCE | 5.08 |
| RESISTANCE | 5.08 |
| RESISTANCE | 5.08 |
| RESISTANCE | 5.08 |
| RESISTANCE | 5.08 |
002424 Forecast December 2025
| 4th UP Forecast | 6.18 |
| 3rd UP Forecast | 5.83 |
| 2nd UP Forecast | 5.61 |
| 1st UP Forecast | 5.39 |
| 1st DOWN Forecast | 4.77 |
| 2nd DOWN Forecast | 4.55 |
| 3rd DOWN Forecast | 4.33 |
| 4th DOWN Forecast | 3.98 |
002424 Weekly Forecast
| 4th UP Forecast | 5.50 |
| 3rd UP Forecast | 5.37 |
| 2nd UP Forecast | 5.28 |
| 1st UP Forecast | 5.20 |
| 1st DOWN Forecast | 4.96 |
| 2nd DOWN Forecast | 4.88 |
| 3rd DOWN Forecast | 4.79 |
| 4th DOWN Forecast | 4.66 |
002424 Forecast2025
| 4th UP Forecast | 11.71 |
| 3rd UP Forecast | 9.58 |
| 2nd UP Forecast | 8.27 |
| 1st UP Forecast | 6.95 |
| 1st DOWN Forecast | 3.21 |
| 2nd DOWN Forecast | 1.89 |
| 3rd DOWN Forecast | 0.58 |
| 4th DOWN Forecast | -1.55 |
Guizhou Bailing Group Pharmaceutical Co. Ltd ( SHE China Symbol : 002424 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
002424 Other Details
| Segment | EQ | |
| Market Capital | 8029728256.00 | |
| Sector | Healthcare | |
| Industry | Drug Manufacturers-Specialty & Generic | |
| Offical website | > echo $website ; ?> | |
002424 Address
![]() |
||
002424 Latest News
002424 Business Profile
Guizhou Bailing Group Pharmaceutical Co., Ltd. researches, develops, produces, and sells Chinese medicines in China. The company provides medicines in the form of tablets, capsules, granules, syrups, pills, powders, tinctures, sprays, and ointments for cardiovascular and cerebrovascular diseases, cough, cold, pediatric, and gynecologic diseases. Guizhou Bailing Group Pharmaceutical Co., Ltd. was founded in 2005 and is based in Anshun, China. Address: Eco & Tech Dev Zn, Anshun, China
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service

